Garner Raises $118M and Becomes Care Navigation Unicorn

This year’s been good for the unicorns, and care navigation startup Garner just became the latest member of the herd after closing $118M of Series D funding at a $1.35B valuation.

Show us the incentives and we’ll show you the outcomes. Garner’s proprietary provider-ranking engine helps patients find the best doctors for their needs, then creates financial incentives to actually go and see them.

  • The engine runs on de-identified data from over 320M patients, which gives Garner the evidence it needs to identify doctors that produce the best outcomes and lowest costs.
  • Every metric answers an important question. Which doctors follow the latest research? Who avoids unnecessary procedures? Who gets patients healthy the fastest? 

Those top providers put up some impressive stat lines. 

  • 75% fewer complications
  • 60% fewer hospitalizations
  • 3x greater adherence to medical guidelines 

Garner takes it a step further. Instead of the usual services-heavy care navigation strategy, Garner’s engine has the incentives for real behavior change baked in. 

  • When employees choose a top provider, Garner picks up the tab – copays, deductibles, and even some procedures. 

The end result speaks for itself. Garner’s clients see a 12% average reduction in total healthcare spending, and their healthy employees are happy employees.

  • Garner already works with 700 organizations reaching 2.5M members, and revenue was up 130% last year as employers increasingly look beyond traditional approaches to combat rising costs. 

What’s next? The fresh funds were earmarked for bolstering the provider-ranking engine, scaling AI navigation capabilities, and growing its team to keep up with demand.

The Takeaway

If data on complication rates and hospital readmissions can help identify the best physicians, then it should also be able to reduce overall costs. Seems like a sound thesis, and Garner just scored another $118M to prove it.

Function Lands $298M for Medical Intelligence

The face of the health membership movement is now worth $2.5B after Function landed $298M of Series B funding to prove that subscription care is here to stay.

Function is building an “operating system for human health.” The OS “fuses AI with medical expertise to empower 8 billion people to take control of their health and get ahead of disease.”

  • Translation: Function offers personalized nutrition and lifestyle recommendations based on a massive menu of lab tests that members can access for $365 per year.
  • Unlike most annual physicals that measure ~26 biomarkers, Function offers 160+ tests spanning from the heart and hormones to heavy metals and cancer signals.
  • It also doubled down with the acquisition of Ezra earlier this year, adding AI-guided full-body MRIs (for detecting cancers, endometriosis, strokes) and CT scans (for lung tumors, heart plaque, soft tissue damage).

The Medical Intelligence Lab takes the vision even further. Function just launched its Medical Intelligence Lab to unify all of its data – labs, imaging, wearables, and medical records – into a continuously learning model designed to reveal patterns and surface actionable insights.

The lab gives members immediate access to three new AI capabilities:

  • Private AI Chat – answers health questions with responses informed by member data.
  • Protocols – translate complex data into health plans with easy-to-follow steps.
  • Health Records – members can securely upload lab results, visit notes, and medical records to feed into Private AI Chat and Protocols.

The testing gold rush is here… but that might not be great for everyone. Research has shown that direct-to-consumer testing companies have a history of wading into murky waters, particularly misleading marketing and a lack of care continuity.

  • Function will have to prove that its benefits outweigh those risks, but hundreds of thousands of members are already voting with their wallets that the math checks out.

The Takeaway

Function will tell you that it isn’t just leading a new category, it’s setting the standard for how we understand, manage, and extend human health. If that turns out to be true, then $298M should go a long way toward proving it.

Fabric Continues Acquisition Spree With UCM

Fabric is back at it again with its fifth acquisition in less than three years, picking up telehealth provider UCM Digital Health to round out its virtual care portfolio.

Here’s a look at Fabric’s M&A journey since launching in 2023 to tackle capacity constraints:

  • May 2023 – Fabric nabs Zipnosis from Bright Health to expand into asynchronous care.
  • Jan 2024 – Fabric scoops up GYANT to provide an AI-entry point to its services.
  • June 2024 – Fabric acquires MeMD and its 30k payor/employer partners from Walmart.
  • Sept 2024 – Fabric broadened its provider network by acquiring TeamHealth VirtualCare.
  • Nov 2025 – Fabric leans in on payors and employers with UCM Digital Health.

End-to-end platforms are built brick-by-brick. Fabric got its start by bringing consumer mobile app experiences to the ER, but it’s quickly expanded into new verticals and use cases.

  • The acquisition spree has grown Fabric into a comprehensive access and experience platform backed by its own medical group, which allows it to streamline virtual-first care for patients across the country.

Fabric’s Hybrid AI is the connective tissue. It automates routine processes to make all the M&A pieces fit together, while also streamlining care coordination and clinical decision support to make its providers more efficient. 

  • By reducing provider work time to just 89 seconds for asynchronous visits, Fabric enables faster treatments for patients and saves payors up to $17 per member per month – all while maintaining outcomes on par with in-person care.

What’s the end result? Salvaging MeMD from the rubble of Walmart’s telehealth business already gave Fabric a strong foothold in the payor/employer market, and UCM will deepen its impact.

  • UCM adds another 400 payor and employer customers to the mix. They’ll transition to the Fabric platform and reap the benefits of its national provider network and polished patient experiences.
  • That brings Fabric’s total client roster to over 75 health systems, 30k employers, and more than 100M lives across all 50 states. Not too shabby for a startup still looking forward to its third birthday.

The Takeaway

Fabric’s been acquiring and integrating new platform capabilities as fast as any digital health company out there, and the “buy-and-build” approach definitely seems to be working. They might be spinning a lot of plates, but they haven’t dropped one yet.

Hippocratic Closes Series C to Fuel Patient-Facing Agents

Rising tides lift all boats, and the venture-backed surge in AI startups just helped boost Hippocratic AI’s valuation to $3.5B on the back of $126M in Series C funding.

Do no harm. Hippocratic’s “safety-focused” AI agents perform almost any low-risk, patient-facing task under the sun. 

  • That includes appointment scheduling, patient intake history, SDOH surveys, health risk assessments, post-discharge outreach, and even chronic condition management.
  • They don’t diagnose patients or prescribe medications… at least not yet.

The Polaris Safety Constellation Architecture makes it all possible. Hippocratic’s healthcare LLM constellation leverages multiple specialized models that “double-check the primary model to ensure accuracy and safety.”

  • The company then performs output testing, human evaluations, and cross-validations to make sure its models’ real-world performance lives up to their simulated testing.

Hippocratic is moving quickly. In just 15 months since commercialization, it’s established partnerships with over 50 major health systems, payors, and pharma clients in six countries.

  • Many of those health system partners have also become investors after being “very impressed” on the safety front, including Universal Health Services, Cincinnati Children’s, and WellSpan Health.
  • The AI agents have already expanded to more than 1,000 use cases and completed upwards of 115M patient interactions – with no reported safety issues.

The nine-figure round sets the tone for the next chapter. Hippocratic earmarked the funding to usher in an “era of abundance” that healthcare has never seen before.

  • At the tactical level, that will involve fueling expansion through mergers and acquisitions, accelerating product development, and leaning in on international growth.

The Takeaway

Whether business makes bubbles or bubbles make business, raising another $143M from industry insiders makes it seem like business is booming at Hippocratic AI.

Assort Health Raises $76M for Experience Agents

A good patient experience starts with a good first impression, and Assort Health just closed $76M of Series B funding to prove its AI agents can deliver exactly that.

Accessing care is a painful process. The Assort OS platform delivers AI agents that can help manage patients’ needs, give staff more bandwidth for higher-level tasks, and reduce friction (AKA frustration) for everyone involved.

  • The agents go beyond scheduling, handling everything from care navigation and prescription renewals to physician referrals and lab tests. 

Goodbye hold music, hello agents. Providers have less staff to manage more patients, so they’re desperately looking for ways to offload the burden on the front office. Voice agents have become the go-to solution, and it’s tough to stand out.

Assort lists several core features that separate it from the pack:

  • Specialty-specific agents – PCPs and oncologists aren’t asking patients the same questions, and Assort adapts to the unique needs of each specialty.  
  • Seamless integration – Assort’s agents integrate directly into the EHR and practice management systems, allowing them to work within the unique clinical rules and workflows of each provider.
  • 90% resolution rate – The specialty-specific tuning allows Assort’s agents to maintain a resolution rate above 90%, while limiting errors like misdirected referrals.

Momentum builds momentum. There might be a ton of startups jumping into the voice AI arena, but not many are closing a Series B less than four months after their Series A

  • Assort’s investors will tell you that it’s “leading the re-platforming of patient engagement into the AI-native era.” At least they’re putting their money where their mouth is.
  • Assort now plans to use the $102M it’s raised over the last four months to get its agents into as many practices as possible before the competition gets their first.

The Takeaway

The race is on to transform the patient experience with the magic of AI, and Assort might just have enough agents (and VC dollars) to pull a rabbit out of its hat.

Medallion Lands $43M and Unveils First National Credentialing Clearinghouse

Medallion keeps building its case to be the go-to platform for provider network management after locking in another $43M and unveiling the industry’s first national credentialing clearinghouse, CredAlliance.

Less friction, more healthcare. Providers have to jump through countless operational and compliance hoops before they can start caring for patients, and Medallion specializes in AI-powered hoop jumping.

  • Medallion helps automate away the back-office workflows that delay care – and revenue – such as credentialing, enrollment, and monitoring.
  • The platform not only onboards providers 40X faster (cutting intake time from 8 days to under 2 hours), but it also serves as a unified system of record that allows customers to verify credentials, stay in-network, and connect patients to care more efficiently.

Own the market by shrinking it. There’s roughly 4M credentialed providers in the U.S., and they’re each contracted with an average of 19 payors. That adds up to about 25M times a year that providers need to get credentialed.

  • The launch of CredAlliance will allow payors to verify providers once and syndicate results, eliminating duplicative work and reducing costs for everyone involved.
  • That has the potential to eliminate $1.2B in duplicative spend annually, but it could also shrink the exact market that Medallion exists to serve. It’s a risk they’re willing to take.

What’s next? The fresh funds will bring Medallion’s AI automation to thousands of state-, provider-, and payor-specific workflows, while simultaneously scaling CredAlliance across more payors.

  • CredAlliance already has dozens of payors signed on, and it’s in talks to bring on five of the nation’s 10 largest health plans.
  • If that ends up making credentialing so efficient that there’s less of a need for automation, we’ll chalk it up as a good thing for the industry and Medallion will be just fine (enterprise ARR is up 106% in the wake of launching three new products – Privileging, Integration Engine, and CAQH Management).

The Takeaway

Medallion had a front row view of the wasteful spending in the credentialing trenches, and it raised $43M to help eliminate it with the first national credentialing clearinghouse. Bravo.

Ambience Healthcare Joins Unicorn Club With Series C Raise

Another week, another ambient AI mega-round – this time from none other than Ambience Healthcare and its massive $243M Series C.

Welcome to the unicorn club. The round vaulted Ambience’s valuation to $1.25B, making it the second-highest valued startup in the ambient arena behind Abridge, which was valued at an eye-popping $5.3B during its recent $300M Series E.

  • Funnily enough, a16z led both rounds. We don’t usually see VCs cut a check for a startup then turn around and fund their biggest competitor, but playing both sides is a great way to not lose a race.

Ambience isn’t just a scribe. It’s an ambient AI platform for documentation, coding, and clinical documentation integrity.

  • The platform was “architected with the understanding that health systems are not monolithic enterprises” and adapts to the unique context of different care settings.

If you ain’t first, you’re last. Ambience was one of the only ambient AI players to lean in on the revenue cycle component right out of the gate, and the head start is reflected in the results from head-to-head pilots.

  • During a six month bake-off at Cleveland Clinic (now a happy customer), Ambience saw 80% clinician utilization and an NPS of 60, both the highest by a wide margin.
  • Ambience Co-Founder Nikhil Buduma told us that the secret sauce is the platform’s ability to make clinicians feel like “it’s almost reading their minds,” which is made possible by continuous fine-tuning the model for individual specialties.

Where do we go from here? If the launch of Doximity’s free scribe taught us anything, it’s that documentation is officially a commodity. Ambience’s new funds will help it do everything else.

  • That includes diving deeper into the revenue cycle and clinical trials, as well as moving upstream into taking care of patients outside of the four walls of the clinic.
  • It also includes scaling up operations, and Ambience has already begun hiring dozens of former startup founders to lead its new verticals.

The Takeaway

We’re now in a world where perfect transcripts are table stakes, which means the winners of the ambient AI race will be the companies that can help carry the tasks happening after the clinical conversation. Ambience just bulked up to do some heavy lifting.

Fortuna Closes Series A to Modernize Medicaid Access

It never hurts to be at the right place at the right time, and Medicaid navigation platform Fortuna Health just landed $18M of Series A funding in the wake of one of the biggest shakeups the safety net coverage program has ever seen.

Medicaid is complicated. Each of the 56 Medicaid programs in the U.S. has its own evolving eligibility rules, documentation standards, and renewal timelines – none of which are easy for anyone to keep track of.

  • Fortuna consolidates these programs into a single interface for patients and members, allowing them to manage their eligibility and applications while getting guided through the obstacle course.
  • For anyone with some time to spare for an exhaustive overview of Fortuna and the broader Medicaid market, look no further than HTN’s stellar interview with CEO Nikita Singareddy.

“TurboTax for Medicaid.” That’s the basic pitch to Fortuna’s payor and provider customers. 

  • Managed care plans and payors get a way to offload backend compliance work and “become invaluable to their members” by putting a Medicaid navigator in their pocket.
  • Health systems and other provider orgs get a way to maximize revenue / retention by helping more patients get (and stay) enrolled in Medicaid or navigate their way to financial support from partners like Cedar.

Over 71M people are currently covered by Medicaid, and One Big Beautiful Bill just reshuffled the rulebook for all of them.

  • OBBB includes roughly $1T in cuts to safety net coverage, as well as new proof-of-work restrictions, documentation requirements, and more frequent eligibility checks.
  • The CBO expects 10M people to lose coverage by 2034 as a result, and Fortuna plans to use its Series A to scale nationwide (it’s currently in 10 states) and invest in AI features that will help respond to the policy shifts.

The Takeaway

As long as Medicaid exists, there’s a place for software that makes enrolling easier. Medicaid infrastructure is long overdue for a healthy dose of AI modernization, and an extra $18M certainly won’t hurt Fortuna’s chances of being the company that makes it happen.

OpenEvidence Locks in $210M Series B in Second Raise of the Year

OpenEvidence might just be the hottest startup in healthcare after locking in another $210M of Series B funding and tripling its valuation to a whopping $3.5B.

Déjà vu. If that sounds familiar, it’s probably because OpenEvidence first joined the unicorn club just five short months ago when it notched a $1B valuation through its $75M Series A.

  • Since then, the LLM-powered medical search engine inked a multi-year content agreement with JAMA to bring full-text articles directly to its platform, and continued to add new doctors at the breakneck pace of 65k per month.
  • It turns out that getting doctors to use a sleek new AI tool isn’t the hardest thing in the world when you make it available at no cost, and over 40% of doctors in the U.S. apparently don’t mind a few pharma ads if you can make their job easier.

Does that justify the valuation? Depends what physician trust is worth. OpenEvidence has added over 430k verified physicians since launching in 2023, and they’re now supporting over 8.5M clinical consultations every month.

  • The volume of medical research published annually is doubling every five years, and physicians are flocking to OpenEvidence so that they can search once, skip the scavenger hunt, and surface the science in seconds.
  • That type of growth is nearly unprecedented in healthcare, and investors are looking to capitalize by dogpiling into startups like OpenEvidence and Abridge, which also raised back-to-back megarounds in the first half of the year.

OpenEvidence is only ramping up from here. CEO Daniel Nadler told Forbes that he views the commoditization of AI copilots similar to TV streaming services, which have to differentiate around content and partnerships.

  • The Series B funds will help OpenEvidence add more strategic content to its medical knowledge library, and fuel new products that can take advantage of it – including its new DeepConsult research assistant.
  • DeepConsult helps physicians get up to speed on a topic by cross-referencing hundreds of studies to deliver comprehensive Ph.D.-level research reports in a matter of hours.

The Takeaway

OpenEvidence is off to the races, and “the fastest-growing platform for doctors in history” still hasn’t even started charging doctors to use it.

Abridge Moves Upstream With $300M Series E

The ambient AI segment is turning into a bigger spectacle than the NBA Finals, and Abridge just dunked on it with $300M of Series E funding.

Big-time startups have big-time valuations. The latest round doubled Abridge’s valuation to $5.3B, up from a paltry $2.5B when it closed its last nine-figure round four short months ago.

  • We’ll leave it to the VCs to decide whether Abridge is worth twice as much as it was in February, but it’s now deployed at 50% more health systems – over 150 in total.
  • Abridge also reportedly hit $117M in contracted annual recurring revenue as of Q1, and is on pace to support upwards of 50M medical conversations this year alone.

Abridge is aiming upstream. The new capital was earmarked for “automating more of what happens behind the scenes and enabling revenue cycle management teams to operate with unparalleled efficiency.” 

  • That means embedding revenue cycle intelligence earlier in the clinical conversation, and eliminating unnecessary back-and-forth between clinicians and billing teams.
  • In Abridge’s own words, the ultimate aim is to “help achieve faster reimbursement cycles and minimize the risk of denials.”

The ambient AI race needs a rebrand. As Abridge and its competitors start lunging toward every workflow within arms reach of the clinical conversation, their platforms are quickly pushing past documentation. Within just the last week:

  • Ambience Healthcare announced that its coding-aware ambient AI platform saves St. Luke’s Health System $13k+ per clinician annually, then followed that up by launching Patient Recap for pre-visit chart summaries.
  • Commure raised $200M and rounded out its RCM and documentation capabilities with AI agents that handle scheduling, referrals, and prior auths. 
  • Nabla closed $70M to build out an Adaptic Agentic Platform that enables real-time coding assistance, direct EHR commands, and new capabilities for nurses.
  • There’s also the 1,000 pound gorilla formerly known as Nuance, but the incumbent scribing champ hasn’t been too vocal since rolling out Microsoft Dragon Copilot earlier this year.

The Takeaway

The hottest segment in digital health is boiling over into revenue cycle management, and Abridge is cranking up the heat with its Series E funding. Topping off the warchest comes with golden strings attached, so expect the pace to only accelerate from here as Abridge looks to live up to its valuation by coming out on top in the RCM landgrab.

Get the top digital health stories right in your inbox